Hyperphosphatemia Clinical Trials

126 clinical trials for Hyperphosphatemia across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia — RECRUITING · PHASE2
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) — RECRUITING
• A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China — RECRUITING · PHASE3
• Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE) — RECRUITING · NA
• Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia — RECRUITING · PHASE2
• An open, randomized, controlled, parallel group, Phase III study to investigate the safety and efficacy of fermagate and lanthanum carbonate together with a randomized placebo controlled double blind fermagate comparison in hemodialysis patients with hyperphosphatemia — COMPLETED · PHASE3
• A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia — COMPLETED · PHASE3
• Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia — COMPLETED · PHASE3
• A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia — COMPLETED · PHASE3
• A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia — COMPLETED · PHASE3
• Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects — COMPLETED · PHASE1
• A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia — COMPLETED · PHASE3
• AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia — COMPLETED · PHASE3
• Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease — COMPLETED · PHASE3
• Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients — COMPLETED · PHASE4
• Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis — COMPLETED · NA
• Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients — OTHER
• Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule — OTHER
• Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis — COMPLETED · PHASE3
• Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease — COMPLETED · NA
• A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD — COMPLETED · PHASE2
• Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients — COMPLETED · PHASE2
• Dose-finding Study of KHK7791 in Hyperphosphatemia Patients — COMPLETED · PHASE2
• A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients — COMPLETED · PHASE2
• Improving Phosphate Control in Children With CKD — OTHER
• Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol — TERMINATED · PHASE4
• Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis — COMPLETED · PHASE3
• A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis — COMPLETED · PHASE3
• A Study of Ferric Citrate to Improve Inflammation and Lipid Levels — TERMINATED · PHASE4
• A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP — COMPLETED · PHASE4
• Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia — COMPLETED · PHASE4
• Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy — COMPLETED · PHASE2
• Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants — COMPLETED · PHASE4
• A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients — COMPLETED · PHASE2
• Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients — COMPLETED · PHASE4
• Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China — COMPLETED · PHASE3
• Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes — COMPLETED
• Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients — COMPLETED · PHASE4
• Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis — COMPLETED · PHASE3
• Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis — COMPLETED · PHASE3
• Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis — COMPLETED · PHASE3
• Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients — COMPLETED · PHASE3
• To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder — OTHER · PHASE1
• Long-term Effect of Lanthanum Carbonate on Bone — COMPLETED
• A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis — COMPLETED · PHASE2
• PA21 Safety and Efficacy in Adult Chinese Subjects — COMPLETED · PHASE3
• Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol) — COMPLETED
• Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia — COMPLETED · NA
• Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis — COMPLETED · PHASE3
• Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia — OTHER · PHASE4

Refine this search